Regulatory

>

Latest News

FDA Approves SpringWorks Therapeutics’ Gomekli for Neurofibromatosis Type 1, Symptomatic Plexiform Neurofibromas
FDA Approves SpringWorks Therapeutics’ Gomekli for Neurofibromatosis Type 1, Symptomatic Plexiform Neurofibromas

February 12th 2025

Approval makes Gomekli the first treatment to be approved for both adults and pediatric patients for neurofibromatosis type 1, a genetic disorder that causes noncancerous tumors to grow on nerves throughout the body.

Monica Martin de Bustamante
Changing Political Winds and the IRA: Q&A with Monica Martin de Bustamante

February 12th 2025

FDA Approves AbbVie’s Emblaveo for Complicated Intra-Abdominal Infections
FDA Approves AbbVie’s Emblaveo for Complicated Intra-Abdominal Infections

February 11th 2025

FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease

February 7th 2025

More News